Production and Purification of Mesenchymal Stem Cell-Derived Extracellular Vesicles Using Preferential Exclusion...

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Biology

Background:

• Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show therapeutic promise for regeneration and reducing inflammation.
• Current MSC-EV production and isolation methods lack scalability and consistent quality/quantity control.
• Heterogeneity in EV size and composition complicates upstream and downstream processing.

Purpose of the Study:

• To develop a scalable chromatographic method for isolating and purifying MSC-EVs.
• To address the challenges posed by EV heterogeneity in bioprocessing.
• To ensure desired quality and quantity of EVs for therapeutic use.

Main Methods:

• Development of a chromatographic method based on the preferential exclusion principle.
• Utilized monolithic hydroxyl columns for MSC-EV purification and concentration.
• Employed PATfix biochromatography analytics to track EV-specific surface antigens during process development.

Main Results:

• The method successfully isolates and concentrates MSC-EVs directly from conditioned media.
• Achieved a 97% reduction in protein impurities.
• Achieved a 95% reduction in double-stranded deoxyribonucleic acid (dsDNA)-related impurities.

Conclusions:

• A scalable chromatographic purification method for MSC-EVs has been successfully developed.
• The method effectively removes major impurities, enhancing EV product quality.
• This advancement supports the clinical translation of MSC-EV therapeutics.